Furthermore, high D‐dimer/FDP levels, CLB, and APL‐like immunophenotype are frequently observed in AML with mutated NPM1 harbouring FLT3 or IDH1/2 co‐mutations [2]. The gene discussed is FLT3; the disease is acute myeloid leukemia.